nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Microtubule Inhibition—Docetaxel—skin cancer	0.32	1	CiPCiCtD
Cabazitaxel—Docetaxel—skin cancer	0.302	1	CrCtD
Cabazitaxel—Paclitaxel—Docetaxel—skin cancer	0.172	1	CrCrCtD
Cabazitaxel—TUBB2A—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB6—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB8—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB3—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB4A—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB2B—Docetaxel—skin cancer	0.0134	0.0817	CbGbCtD
Cabazitaxel—TUBB4B—Docetaxel—skin cancer	0.0112	0.0684	CbGbCtD
Cabazitaxel—TUBB1—Docetaxel—skin cancer	0.0112	0.0684	CbGbCtD
Cabazitaxel—TUBB—Docetaxel—skin cancer	0.0112	0.0684	CbGbCtD
Cabazitaxel—ABCG2—Vismodegib—skin cancer	0.00816	0.0498	CbGbCtD
Cabazitaxel—ABCG2—Vemurafenib—skin cancer	0.00645	0.0393	CbGbCtD
Cabazitaxel—SLCO1B3—Docetaxel—skin cancer	0.00478	0.0292	CbGbCtD
Cabazitaxel—CYP2C8—Vismodegib—skin cancer	0.00434	0.0265	CbGbCtD
Cabazitaxel—ABCG2—Dactinomycin—skin cancer	0.00428	0.0261	CbGbCtD
Cabazitaxel—ABCB1—Vismodegib—skin cancer	0.00294	0.0179	CbGbCtD
Cabazitaxel—ABCG2—Fluorouracil—skin cancer	0.0029	0.0177	CbGbCtD
Cabazitaxel—CYP3A4—Temozolomide—skin cancer	0.00254	0.0155	CbGbCtD
Cabazitaxel—CYP3A4—Imiquimod—skin cancer	0.00254	0.0155	CbGbCtD
Cabazitaxel—ABCG2—Docetaxel—skin cancer	0.00221	0.0135	CbGbCtD
Cabazitaxel—CYP3A4—Vismodegib—skin cancer	0.00176	0.0108	CbGbCtD
Cabazitaxel—ABCB1—Dactinomycin—skin cancer	0.00154	0.00943	CbGbCtD
Cabazitaxel—CYP2C8—Fluorouracil—skin cancer	0.00154	0.00942	CbGbCtD
Cabazitaxel—CYP3A4—Vemurafenib—skin cancer	0.00139	0.0085	CbGbCtD
Cabazitaxel—CYP3A5—Docetaxel—skin cancer	0.00123	0.00748	CbGbCtD
Cabazitaxel—ABCB1—Docetaxel—skin cancer	0.000798	0.00487	CbGbCtD
Cabazitaxel—CYP3A4—Docetaxel—skin cancer	0.000478	0.00292	CbGbCtD
Cabazitaxel—TUBB4B—Sorafenib—Vismodegib—skin cancer	0.000467	0.667	CbGdCrCtD
Cabazitaxel—TUBB4B—skin epidermis—skin cancer	0.000426	0.0435	CbGeAlD
Cabazitaxel—TUBB—hair follicle—skin cancer	0.000356	0.0364	CbGeAlD
Cabazitaxel—TUBA4A—nipple—skin cancer	0.000329	0.0336	CbGeAlD
Cabazitaxel—TUBB3—connective tissue—skin cancer	0.000308	0.0314	CbGeAlD
Cabazitaxel—TUBB4B—hair follicle—skin cancer	0.000304	0.031	CbGeAlD
Cabazitaxel—TUBB8—head—skin cancer	0.000266	0.0271	CbGeAlD
Cabazitaxel—TUBB2B—nipple—skin cancer	0.000255	0.0261	CbGeAlD
Cabazitaxel—TUBB—nipple—skin cancer	0.000241	0.0247	CbGeAlD
Cabazitaxel—TUBB2A—nipple—skin cancer	0.00024	0.0245	CbGeAlD
Cabazitaxel—TUBB6—nipple—skin cancer	0.000237	0.0242	CbGeAlD
Cabazitaxel—TUBA4A—connective tissue—skin cancer	0.000234	0.0239	CbGeAlD
Cabazitaxel—TUBB6—Sorafenib—Vismodegib—skin cancer	0.000233	0.333	CbGdCrCtD
Cabazitaxel—TUBB3—lymphoid tissue—skin cancer	0.000225	0.023	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—skin cancer	0.000222	0.0226	CbGeAlD
Cabazitaxel—TUBA4A—skin of body—skin cancer	0.000211	0.0215	CbGeAlD
Cabazitaxel—TUBB4B—nipple—skin cancer	0.000206	0.021	CbGeAlD
Cabazitaxel—TUBA4A—mammalian vulva—skin cancer	0.000192	0.0196	CbGeAlD
Cabazitaxel—TUBB4A—connective tissue—skin cancer	0.000187	0.0191	CbGeAlD
Cabazitaxel—TUBB3—head—skin cancer	0.000181	0.0185	CbGeAlD
Cabazitaxel—TUBB2B—connective tissue—skin cancer	0.000181	0.0185	CbGeAlD
Cabazitaxel—TUBB1—head—skin cancer	0.000177	0.0181	CbGeAlD
Cabazitaxel—TUBA4A—lymphoid tissue—skin cancer	0.000171	0.0174	CbGeAlD
Cabazitaxel—TUBB2A—connective tissue—skin cancer	0.00017	0.0174	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—skin cancer	0.000169	0.0173	CbGeAlD
Cabazitaxel—TUBA4A—female reproductive system—skin cancer	0.000165	0.0168	CbGeAlD
Cabazitaxel—TUBB6—epithelium—skin cancer	0.000159	0.0163	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—skin cancer	0.000154	0.0157	CbGeAlD
Cabazitaxel—TUBB6—skin of body—skin cancer	0.000152	0.0155	CbGeAlD
Cabazitaxel—TUBB2B—mammalian vulva—skin cancer	0.000149	0.0152	CbGeAlD
Cabazitaxel—TUBB4B—connective tissue—skin cancer	0.000146	0.0149	CbGeAlD
Cabazitaxel—TUBB—mammalian vulva—skin cancer	0.000141	0.0144	CbGeAlD
Cabazitaxel—TUBB2A—mammalian vulva—skin cancer	0.00014	0.0143	CbGeAlD
Cabazitaxel—TUBB6—mammalian vulva—skin cancer	0.000138	0.0141	CbGeAlD
Cabazitaxel—TUBA4A—head—skin cancer	0.000138	0.0141	CbGeAlD
Cabazitaxel—TUBB4A—lymphoid tissue—skin cancer	0.000137	0.014	CbGeAlD
Cabazitaxel—TUBB4A—female reproductive system—skin cancer	0.000132	0.0135	CbGeAlD
Cabazitaxel—TUBB4B—skin of body—skin cancer	0.000132	0.0135	CbGeAlD
Cabazitaxel—TUBB2B—female reproductive system—skin cancer	0.000128	0.013	CbGeAlD
Cabazitaxel—TUBB6—lymphoid tissue—skin cancer	0.000123	0.0125	CbGeAlD
Cabazitaxel—TUBB4B—mammalian vulva—skin cancer	0.00012	0.0123	CbGeAlD
Cabazitaxel—TUBB2A—female reproductive system—skin cancer	0.00012	0.0123	CbGeAlD
Cabazitaxel—TUBB6—female reproductive system—skin cancer	0.000118	0.0121	CbGeAlD
Cabazitaxel—TUBB4A—head—skin cancer	0.00011	0.0113	CbGeAlD
Cabazitaxel—SLCO1B1—female reproductive system—skin cancer	0.00011	0.0112	CbGeAlD
Cabazitaxel—TUBB4B—lymphoid tissue—skin cancer	0.000107	0.0109	CbGeAlD
Cabazitaxel—TUBB2B—head—skin cancer	0.000107	0.0109	CbGeAlD
Cabazitaxel—TUBB4B—female reproductive system—skin cancer	0.000103	0.0105	CbGeAlD
Cabazitaxel—TUBB2A—head—skin cancer	0.0001	0.0102	CbGeAlD
Cabazitaxel—TUBB6—head—skin cancer	9.9e-05	0.0101	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—skin cancer	9.64e-05	0.00984	CbGeAlD
Cabazitaxel—TUBB4B—head—skin cancer	8.6e-05	0.00879	CbGeAlD
Cabazitaxel—ABCB1—blood vessel—skin cancer	8.28e-05	0.00846	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—skin cancer	7.72e-05	0.00789	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—skin cancer	7.46e-05	0.00762	CbGeAlD
Cabazitaxel—ABCG2—mammalian vulva—skin cancer	7.09e-05	0.00724	CbGeAlD
Cabazitaxel—TUBB—lymph node—skin cancer	7.06e-05	0.00721	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—skin cancer	7.03e-05	0.00718	CbGeAlD
Cabazitaxel—TUBB6—lymph node—skin cancer	6.93e-05	0.00708	CbGeAlD
Cabazitaxel—CYP2C8—female reproductive system—skin cancer	6.25e-05	0.00638	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—skin cancer	6.02e-05	0.00615	CbGeAlD
Cabazitaxel—Decreased appetite—Imiquimod—skin cancer	5.26e-05	0.00166	CcSEcCtD
Cabazitaxel—Hot flush—Docetaxel—skin cancer	5.25e-05	0.00166	CcSEcCtD
Cabazitaxel—Infestation—Fluorouracil—skin cancer	5.24e-05	0.00165	CcSEcCtD
Cabazitaxel—Infestation NOS—Fluorouracil—skin cancer	5.24e-05	0.00165	CcSEcCtD
Cabazitaxel—Flushing—Dactinomycin—skin cancer	5.24e-05	0.00165	CcSEcCtD
Cabazitaxel—Hypersensitivity—Vemurafenib—skin cancer	5.23e-05	0.00165	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Imiquimod—skin cancer	5.23e-05	0.00165	CcSEcCtD
Cabazitaxel—Fatigue—Imiquimod—skin cancer	5.22e-05	0.00165	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Docetaxel—skin cancer	5.2e-05	0.00164	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Docetaxel—skin cancer	5.18e-05	0.00163	CcSEcCtD
Cabazitaxel—Pain—Imiquimod—skin cancer	5.18e-05	0.00163	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Fluorouracil—skin cancer	5.14e-05	0.00162	CcSEcCtD
Cabazitaxel—Urinary tract infection—Fluorouracil—skin cancer	5.1e-05	0.00161	CcSEcCtD
Cabazitaxel—Conjunctivitis—Fluorouracil—skin cancer	5.1e-05	0.00161	CcSEcCtD
Cabazitaxel—Asthenia—Vemurafenib—skin cancer	5.09e-05	0.00161	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Temozolomide—skin cancer	5.08e-05	0.0016	CcSEcCtD
Cabazitaxel—Chills—Dactinomycin—skin cancer	5.07e-05	0.0016	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Temozolomide—skin cancer	5.04e-05	0.00159	CcSEcCtD
Cabazitaxel—Oedema peripheral—Temozolomide—skin cancer	5.03e-05	0.00159	CcSEcCtD
Cabazitaxel—Cardiac failure—Docetaxel—skin cancer	5.03e-05	0.00159	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Temozolomide—skin cancer	5.02e-05	0.00158	CcSEcCtD
Cabazitaxel—Lethargy—Docetaxel—skin cancer	5.01e-05	0.00158	CcSEcCtD
Cabazitaxel—Urethral disorder—Temozolomide—skin cancer	5.01e-05	0.00158	CcSEcCtD
Cabazitaxel—Alopecia—Dactinomycin—skin cancer	4.99e-05	0.00157	CcSEcCtD
Cabazitaxel—Feeling abnormal—Imiquimod—skin cancer	4.99e-05	0.00157	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Imiquimod—skin cancer	4.95e-05	0.00156	CcSEcCtD
Cabazitaxel—Erythema—Dactinomycin—skin cancer	4.92e-05	0.00155	CcSEcCtD
Cabazitaxel—Pain in extremity—Docetaxel—skin cancer	4.91e-05	0.00155	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Docetaxel—skin cancer	4.91e-05	0.00155	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Bleomycin—skin cancer	4.89e-05	0.00154	CcSEcCtD
Cabazitaxel—Anaemia—Bleomycin—skin cancer	4.87e-05	0.00154	CcSEcCtD
Cabazitaxel—Diarrhoea—Vemurafenib—skin cancer	4.86e-05	0.00153	CcSEcCtD
Cabazitaxel—Abdominal pain—Imiquimod—skin cancer	4.79e-05	0.00151	CcSEcCtD
Cabazitaxel—Body temperature increased—Imiquimod—skin cancer	4.79e-05	0.00151	CcSEcCtD
Cabazitaxel—Eye disorder—Temozolomide—skin cancer	4.77e-05	0.00151	CcSEcCtD
Cabazitaxel—Tinnitus—Temozolomide—skin cancer	4.76e-05	0.0015	CcSEcCtD
Cabazitaxel—Malaise—Bleomycin—skin cancer	4.75e-05	0.0015	CcSEcCtD
Cabazitaxel—Flushing—Temozolomide—skin cancer	4.74e-05	0.00149	CcSEcCtD
Cabazitaxel—Cardiac disorder—Temozolomide—skin cancer	4.74e-05	0.00149	CcSEcCtD
Cabazitaxel—Leukopenia—Bleomycin—skin cancer	4.72e-05	0.00149	CcSEcCtD
Cabazitaxel—Dizziness—Vemurafenib—skin cancer	4.69e-05	0.00148	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Fluorouracil—skin cancer	4.68e-05	0.00148	CcSEcCtD
Cabazitaxel—Angiopathy—Temozolomide—skin cancer	4.63e-05	0.00146	CcSEcCtD
Cabazitaxel—Immune system disorder—Temozolomide—skin cancer	4.61e-05	0.00145	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Temozolomide—skin cancer	4.6e-05	0.00145	CcSEcCtD
Cabazitaxel—Cough—Bleomycin—skin cancer	4.6e-05	0.00145	CcSEcCtD
Cabazitaxel—Chills—Temozolomide—skin cancer	4.58e-05	0.00145	CcSEcCtD
Cabazitaxel—Dehydration—Docetaxel—skin cancer	4.57e-05	0.00144	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Dactinomycin—skin cancer	4.56e-05	0.00144	CcSEcCtD
Cabazitaxel—Anaemia—Dactinomycin—skin cancer	4.54e-05	0.00143	CcSEcCtD
Cabazitaxel—Vomiting—Vemurafenib—skin cancer	4.51e-05	0.00142	CcSEcCtD
Cabazitaxel—Alopecia—Temozolomide—skin cancer	4.51e-05	0.00142	CcSEcCtD
Cabazitaxel—Dry skin—Docetaxel—skin cancer	4.5e-05	0.00142	CcSEcCtD
Cabazitaxel—Chest pain—Bleomycin—skin cancer	4.49e-05	0.00142	CcSEcCtD
Cabazitaxel—Myalgia—Bleomycin—skin cancer	4.49e-05	0.00142	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Docetaxel—skin cancer	4.48e-05	0.00141	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Docetaxel—skin cancer	4.48e-05	0.00141	CcSEcCtD
Cabazitaxel—Mental disorder—Temozolomide—skin cancer	4.47e-05	0.00141	CcSEcCtD
Cabazitaxel—Hypersensitivity—Imiquimod—skin cancer	4.46e-05	0.00141	CcSEcCtD
Cabazitaxel—Headache—Vemurafenib—skin cancer	4.45e-05	0.0014	CcSEcCtD
Cabazitaxel—Erythema—Temozolomide—skin cancer	4.45e-05	0.0014	CcSEcCtD
Cabazitaxel—Malnutrition—Temozolomide—skin cancer	4.45e-05	0.0014	CcSEcCtD
Cabazitaxel—Breast disorder—Docetaxel—skin cancer	4.44e-05	0.0014	CcSEcCtD
Cabazitaxel—Discomfort—Bleomycin—skin cancer	4.43e-05	0.0014	CcSEcCtD
Cabazitaxel—Malaise—Dactinomycin—skin cancer	4.43e-05	0.0014	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Docetaxel—skin cancer	4.42e-05	0.00139	CcSEcCtD
Cabazitaxel—Leukopenia—Dactinomycin—skin cancer	4.4e-05	0.00139	CcSEcCtD
Cabazitaxel—Dysgeusia—Temozolomide—skin cancer	4.35e-05	0.00137	CcSEcCtD
Cabazitaxel—Asthenia—Imiquimod—skin cancer	4.34e-05	0.00137	CcSEcCtD
Cabazitaxel—Confusional state—Bleomycin—skin cancer	4.34e-05	0.00137	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Docetaxel—skin cancer	4.33e-05	0.00137	CcSEcCtD
Cabazitaxel—Oedema—Bleomycin—skin cancer	4.3e-05	0.00136	CcSEcCtD
Cabazitaxel—Back pain—Temozolomide—skin cancer	4.3e-05	0.00136	CcSEcCtD
Cabazitaxel—Infection—Bleomycin—skin cancer	4.27e-05	0.00135	CcSEcCtD
Cabazitaxel—CYP3A4—female reproductive system—skin cancer	4.23e-05	0.00432	CbGeAlD
Cabazitaxel—Nausea—Vemurafenib—skin cancer	4.22e-05	0.00133	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Bleomycin—skin cancer	4.21e-05	0.00133	CcSEcCtD
Cabazitaxel—Arrhythmia—Fluorouracil—skin cancer	4.2e-05	0.00133	CcSEcCtD
Cabazitaxel—Myalgia—Dactinomycin—skin cancer	4.18e-05	0.00132	CcSEcCtD
Cabazitaxel—Alopecia—Fluorouracil—skin cancer	4.16e-05	0.00131	CcSEcCtD
Cabazitaxel—Diarrhoea—Imiquimod—skin cancer	4.14e-05	0.00131	CcSEcCtD
Cabazitaxel—Discomfort—Dactinomycin—skin cancer	4.13e-05	0.0013	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Temozolomide—skin cancer	4.12e-05	0.0013	CcSEcCtD
Cabazitaxel—Anaemia—Temozolomide—skin cancer	4.11e-05	0.0013	CcSEcCtD
Cabazitaxel—Anorexia—Bleomycin—skin cancer	4.1e-05	0.00129	CcSEcCtD
Cabazitaxel—Erythema—Fluorouracil—skin cancer	4.1e-05	0.00129	CcSEcCtD
Cabazitaxel—ABCB1—epithelium—skin cancer	4.03e-05	0.00412	CbGeAlD
Cabazitaxel—Hypotension—Bleomycin—skin cancer	4.02e-05	0.00127	CcSEcCtD
Cabazitaxel—Oedema—Dactinomycin—skin cancer	4.01e-05	0.00127	CcSEcCtD
Cabazitaxel—Malaise—Temozolomide—skin cancer	4.01e-05	0.00126	CcSEcCtD
Cabazitaxel—Dizziness—Imiquimod—skin cancer	4e-05	0.00126	CcSEcCtD
Cabazitaxel—Vertigo—Temozolomide—skin cancer	3.99e-05	0.00126	CcSEcCtD
Cabazitaxel—Infection—Dactinomycin—skin cancer	3.99e-05	0.00126	CcSEcCtD
Cabazitaxel—Leukopenia—Temozolomide—skin cancer	3.98e-05	0.00126	CcSEcCtD
Cabazitaxel—Neutropenia—Docetaxel—skin cancer	3.97e-05	0.00125	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Dactinomycin—skin cancer	3.93e-05	0.00124	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Bleomycin—skin cancer	3.92e-05	0.00124	CcSEcCtD
Cabazitaxel—Cough—Temozolomide—skin cancer	3.88e-05	0.00122	CcSEcCtD
Cabazitaxel—Paraesthesia—Bleomycin—skin cancer	3.86e-05	0.00122	CcSEcCtD
Cabazitaxel—Vomiting—Imiquimod—skin cancer	3.85e-05	0.00121	CcSEcCtD
Cabazitaxel—Weight decreased—Docetaxel—skin cancer	3.84e-05	0.00121	CcSEcCtD
Cabazitaxel—Hypertension—Temozolomide—skin cancer	3.84e-05	0.00121	CcSEcCtD
Cabazitaxel—Dyspnoea—Bleomycin—skin cancer	3.83e-05	0.00121	CcSEcCtD
Cabazitaxel—Anorexia—Dactinomycin—skin cancer	3.82e-05	0.00121	CcSEcCtD
Cabazitaxel—Pneumonia—Docetaxel—skin cancer	3.81e-05	0.0012	CcSEcCtD
Cabazitaxel—Headache—Imiquimod—skin cancer	3.79e-05	0.0012	CcSEcCtD
Cabazitaxel—Anaemia—Fluorouracil—skin cancer	3.79e-05	0.00119	CcSEcCtD
Cabazitaxel—Myalgia—Temozolomide—skin cancer	3.78e-05	0.00119	CcSEcCtD
Cabazitaxel—Arthralgia—Temozolomide—skin cancer	3.78e-05	0.00119	CcSEcCtD
Cabazitaxel—Infestation NOS—Docetaxel—skin cancer	3.78e-05	0.00119	CcSEcCtD
Cabazitaxel—Infestation—Docetaxel—skin cancer	3.78e-05	0.00119	CcSEcCtD
Cabazitaxel—Anxiety—Temozolomide—skin cancer	3.77e-05	0.00119	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	3.76e-05	0.00119	CcSEcCtD
Cabazitaxel—Discomfort—Temozolomide—skin cancer	3.74e-05	0.00118	CcSEcCtD
Cabazitaxel—Decreased appetite—Bleomycin—skin cancer	3.74e-05	0.00118	CcSEcCtD
Cabazitaxel—Renal failure—Docetaxel—skin cancer	3.72e-05	0.00117	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Docetaxel—skin cancer	3.71e-05	0.00117	CcSEcCtD
Cabazitaxel—Dry mouth—Temozolomide—skin cancer	3.7e-05	0.00117	CcSEcCtD
Cabazitaxel—Pain—Bleomycin—skin cancer	3.68e-05	0.00116	CcSEcCtD
Cabazitaxel—Conjunctivitis—Docetaxel—skin cancer	3.68e-05	0.00116	CcSEcCtD
Cabazitaxel—Leukopenia—Fluorouracil—skin cancer	3.67e-05	0.00116	CcSEcCtD
Cabazitaxel—Confusional state—Temozolomide—skin cancer	3.66e-05	0.00115	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Dactinomycin—skin cancer	3.65e-05	0.00115	CcSEcCtD
Cabazitaxel—Oedema—Temozolomide—skin cancer	3.63e-05	0.00114	CcSEcCtD
Cabazitaxel—Infection—Temozolomide—skin cancer	3.6e-05	0.00114	CcSEcCtD
Cabazitaxel—Nausea—Imiquimod—skin cancer	3.6e-05	0.00113	CcSEcCtD
Cabazitaxel—Nervous system disorder—Temozolomide—skin cancer	3.56e-05	0.00112	CcSEcCtD
Cabazitaxel—ABCG2—lymph node—skin cancer	3.55e-05	0.00363	CbGeAlD
Cabazitaxel—Thrombocytopenia—Temozolomide—skin cancer	3.55e-05	0.00112	CcSEcCtD
Cabazitaxel—Feeling abnormal—Bleomycin—skin cancer	3.54e-05	0.00112	CcSEcCtD
Cabazitaxel—Skin disorder—Temozolomide—skin cancer	3.52e-05	0.00111	CcSEcCtD
Cabazitaxel—ABCB1—mammalian vulva—skin cancer	3.5e-05	0.00357	CbGeAlD
Cabazitaxel—Chest pain—Fluorouracil—skin cancer	3.49e-05	0.0011	CcSEcCtD
Cabazitaxel—Myalgia—Fluorouracil—skin cancer	3.49e-05	0.0011	CcSEcCtD
Cabazitaxel—Decreased appetite—Dactinomycin—skin cancer	3.49e-05	0.0011	CcSEcCtD
Cabazitaxel—Fatigue—Dactinomycin—skin cancer	3.46e-05	0.00109	CcSEcCtD
Cabazitaxel—Anorexia—Temozolomide—skin cancer	3.46e-05	0.00109	CcSEcCtD
Cabazitaxel—Discomfort—Fluorouracil—skin cancer	3.45e-05	0.00109	CcSEcCtD
Cabazitaxel—Pain—Dactinomycin—skin cancer	3.43e-05	0.00108	CcSEcCtD
Cabazitaxel—Body temperature increased—Bleomycin—skin cancer	3.4e-05	0.00107	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Docetaxel—skin cancer	3.38e-05	0.00107	CcSEcCtD
Cabazitaxel—Confusional state—Fluorouracil—skin cancer	3.37e-05	0.00106	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Docetaxel—skin cancer	3.35e-05	0.00106	CcSEcCtD
Cabazitaxel—Oedema peripheral—Docetaxel—skin cancer	3.35e-05	0.00106	CcSEcCtD
Cabazitaxel—Oedema—Fluorouracil—skin cancer	3.34e-05	0.00105	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Docetaxel—skin cancer	3.34e-05	0.00105	CcSEcCtD
Cabazitaxel—Urethral disorder—Docetaxel—skin cancer	3.33e-05	0.00105	CcSEcCtD
Cabazitaxel—Infection—Fluorouracil—skin cancer	3.32e-05	0.00105	CcSEcCtD
Cabazitaxel—Feeling abnormal—Dactinomycin—skin cancer	3.31e-05	0.00104	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Temozolomide—skin cancer	3.31e-05	0.00104	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dactinomycin—skin cancer	3.28e-05	0.00103	CcSEcCtD
Cabazitaxel—Nervous system disorder—Fluorouracil—skin cancer	3.28e-05	0.00103	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Fluorouracil—skin cancer	3.27e-05	0.00103	CcSEcCtD
Cabazitaxel—Tachycardia—Fluorouracil—skin cancer	3.26e-05	0.00103	CcSEcCtD
Cabazitaxel—Paraesthesia—Temozolomide—skin cancer	3.26e-05	0.00103	CcSEcCtD
Cabazitaxel—Dyspnoea—Temozolomide—skin cancer	3.23e-05	0.00102	CcSEcCtD
Cabazitaxel—Dyspepsia—Temozolomide—skin cancer	3.19e-05	0.00101	CcSEcCtD
Cabazitaxel—Anorexia—Fluorouracil—skin cancer	3.19e-05	0.00101	CcSEcCtD
Cabazitaxel—Eye disorder—Docetaxel—skin cancer	3.17e-05	0.001	CcSEcCtD
Cabazitaxel—Abdominal pain—Dactinomycin—skin cancer	3.17e-05	0.001	CcSEcCtD
Cabazitaxel—Body temperature increased—Dactinomycin—skin cancer	3.17e-05	0.001	CcSEcCtD
Cabazitaxel—Hypersensitivity—Bleomycin—skin cancer	3.17e-05	0.001	CcSEcCtD
Cabazitaxel—Decreased appetite—Temozolomide—skin cancer	3.15e-05	0.000995	CcSEcCtD
Cabazitaxel—Flushing—Docetaxel—skin cancer	3.15e-05	0.000994	CcSEcCtD
Cabazitaxel—Cardiac disorder—Docetaxel—skin cancer	3.15e-05	0.000994	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Temozolomide—skin cancer	3.13e-05	0.000988	CcSEcCtD
Cabazitaxel—Fatigue—Temozolomide—skin cancer	3.13e-05	0.000987	CcSEcCtD
Cabazitaxel—Hypotension—Fluorouracil—skin cancer	3.12e-05	0.000985	CcSEcCtD
Cabazitaxel—ABCB1—lymphoid tissue—skin cancer	3.1e-05	0.00317	CbGeAlD
Cabazitaxel—Pain—Temozolomide—skin cancer	3.1e-05	0.000979	CcSEcCtD
Cabazitaxel—Constipation—Temozolomide—skin cancer	3.1e-05	0.000979	CcSEcCtD
Cabazitaxel—Asthenia—Bleomycin—skin cancer	3.09e-05	0.000973	CcSEcCtD
Cabazitaxel—Angiopathy—Docetaxel—skin cancer	3.08e-05	0.000972	CcSEcCtD
Cabazitaxel—Immune system disorder—Docetaxel—skin cancer	3.07e-05	0.000968	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Docetaxel—skin cancer	3.06e-05	0.000965	CcSEcCtD
Cabazitaxel—Chills—Docetaxel—skin cancer	3.05e-05	0.000961	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Fluorouracil—skin cancer	3.05e-05	0.000961	CcSEcCtD
Cabazitaxel—Arrhythmia—Docetaxel—skin cancer	3.03e-05	0.000957	CcSEcCtD
Cabazitaxel—Paraesthesia—Fluorouracil—skin cancer	3e-05	0.000947	CcSEcCtD
Cabazitaxel—Alopecia—Docetaxel—skin cancer	3e-05	0.000947	CcSEcCtD
Cabazitaxel—ABCB1—female reproductive system—skin cancer	2.99e-05	0.00306	CbGeAlD
Cabazitaxel—Feeling abnormal—Temozolomide—skin cancer	2.99e-05	0.000943	CcSEcCtD
Cabazitaxel—Dyspnoea—Fluorouracil—skin cancer	2.98e-05	0.00094	CcSEcCtD
Cabazitaxel—Mental disorder—Docetaxel—skin cancer	2.98e-05	0.000938	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Temozolomide—skin cancer	2.97e-05	0.000936	CcSEcCtD
Cabazitaxel—Erythema—Docetaxel—skin cancer	2.96e-05	0.000932	CcSEcCtD
Cabazitaxel—Malnutrition—Docetaxel—skin cancer	2.96e-05	0.000932	CcSEcCtD
Cabazitaxel—Hypersensitivity—Dactinomycin—skin cancer	2.96e-05	0.000932	CcSEcCtD
Cabazitaxel—Dyspepsia—Fluorouracil—skin cancer	2.94e-05	0.000928	CcSEcCtD
Cabazitaxel—Decreased appetite—Fluorouracil—skin cancer	2.91e-05	0.000917	CcSEcCtD
Cabazitaxel—Dysgeusia—Docetaxel—skin cancer	2.9e-05	0.000913	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Fluorouracil—skin cancer	2.89e-05	0.00091	CcSEcCtD
Cabazitaxel—Asthenia—Dactinomycin—skin cancer	2.88e-05	0.000908	CcSEcCtD
Cabazitaxel—Abdominal pain—Temozolomide—skin cancer	2.87e-05	0.000905	CcSEcCtD
Cabazitaxel—Body temperature increased—Temozolomide—skin cancer	2.87e-05	0.000905	CcSEcCtD
Cabazitaxel—Back pain—Docetaxel—skin cancer	2.86e-05	0.000902	CcSEcCtD
Cabazitaxel—Pain—Fluorouracil—skin cancer	2.86e-05	0.000902	CcSEcCtD
Cabazitaxel—Muscle spasms—Docetaxel—skin cancer	2.84e-05	0.000897	CcSEcCtD
Cabazitaxel—Feeling abnormal—Fluorouracil—skin cancer	2.75e-05	0.000869	CcSEcCtD
Cabazitaxel—Diarrhoea—Dactinomycin—skin cancer	2.74e-05	0.000866	CcSEcCtD
Cabazitaxel—Vomiting—Bleomycin—skin cancer	2.73e-05	0.000863	CcSEcCtD
Cabazitaxel—Anaemia—Docetaxel—skin cancer	2.73e-05	0.000862	CcSEcCtD
Cabazitaxel—Hypersensitivity—Temozolomide—skin cancer	2.67e-05	0.000843	CcSEcCtD
Cabazitaxel—Leukopenia—Docetaxel—skin cancer	2.65e-05	0.000835	CcSEcCtD
Cabazitaxel—Body temperature increased—Fluorouracil—skin cancer	2.64e-05	0.000834	CcSEcCtD
Cabazitaxel—Asthenia—Temozolomide—skin cancer	2.6e-05	0.000821	CcSEcCtD
Cabazitaxel—Cough—Docetaxel—skin cancer	2.58e-05	0.000814	CcSEcCtD
Cabazitaxel—Nausea—Bleomycin—skin cancer	2.55e-05	0.000806	CcSEcCtD
Cabazitaxel—Hypertension—Docetaxel—skin cancer	2.55e-05	0.000805	CcSEcCtD
Cabazitaxel—Vomiting—Dactinomycin—skin cancer	2.55e-05	0.000804	CcSEcCtD
Cabazitaxel—Myalgia—Docetaxel—skin cancer	2.52e-05	0.000794	CcSEcCtD
Cabazitaxel—Chest pain—Docetaxel—skin cancer	2.52e-05	0.000794	CcSEcCtD
Cabazitaxel—Arthralgia—Docetaxel—skin cancer	2.52e-05	0.000794	CcSEcCtD
Cabazitaxel—ABCB1—head—skin cancer	2.5e-05	0.00256	CbGeAlD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	2.5e-05	0.000788	CcSEcCtD
Cabazitaxel—Diarrhoea—Temozolomide—skin cancer	2.48e-05	0.000783	CcSEcCtD
Cabazitaxel—Hypersensitivity—Fluorouracil—skin cancer	2.46e-05	0.000777	CcSEcCtD
Cabazitaxel—Dry mouth—Docetaxel—skin cancer	2.46e-05	0.000776	CcSEcCtD
Cabazitaxel—Confusional state—Docetaxel—skin cancer	2.43e-05	0.000767	CcSEcCtD
Cabazitaxel—Oedema—Docetaxel—skin cancer	2.41e-05	0.000761	CcSEcCtD
Cabazitaxel—Dizziness—Temozolomide—skin cancer	2.4e-05	0.000757	CcSEcCtD
Cabazitaxel—Infection—Docetaxel—skin cancer	2.4e-05	0.000756	CcSEcCtD
Cabazitaxel—Nausea—Dactinomycin—skin cancer	2.38e-05	0.000752	CcSEcCtD
Cabazitaxel—Nervous system disorder—Docetaxel—skin cancer	2.37e-05	0.000746	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Docetaxel—skin cancer	2.36e-05	0.000745	CcSEcCtD
Cabazitaxel—Tachycardia—Docetaxel—skin cancer	2.35e-05	0.000743	CcSEcCtD
Cabazitaxel—Skin disorder—Docetaxel—skin cancer	2.34e-05	0.000739	CcSEcCtD
Cabazitaxel—Vomiting—Temozolomide—skin cancer	2.31e-05	0.000728	CcSEcCtD
Cabazitaxel—Anorexia—Docetaxel—skin cancer	2.3e-05	0.000725	CcSEcCtD
Cabazitaxel—Diarrhoea—Fluorouracil—skin cancer	2.29e-05	0.000721	CcSEcCtD
Cabazitaxel—Headache—Temozolomide—skin cancer	2.27e-05	0.000717	CcSEcCtD
Cabazitaxel—Hypotension—Docetaxel—skin cancer	2.25e-05	0.000711	CcSEcCtD
Cabazitaxel—Dizziness—Fluorouracil—skin cancer	2.21e-05	0.000697	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Docetaxel—skin cancer	2.2e-05	0.000693	CcSEcCtD
Cabazitaxel—Paraesthesia—Docetaxel—skin cancer	2.17e-05	0.000683	CcSEcCtD
Cabazitaxel—Nausea—Temozolomide—skin cancer	2.16e-05	0.00068	CcSEcCtD
Cabazitaxel—Dyspnoea—Docetaxel—skin cancer	2.15e-05	0.000678	CcSEcCtD
Cabazitaxel—Vomiting—Fluorouracil—skin cancer	2.13e-05	0.00067	CcSEcCtD
Cabazitaxel—Dyspepsia—Docetaxel—skin cancer	2.12e-05	0.00067	CcSEcCtD
Cabazitaxel—Decreased appetite—Docetaxel—skin cancer	2.1e-05	0.000662	CcSEcCtD
Cabazitaxel—Headache—Fluorouracil—skin cancer	2.09e-05	0.000661	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Docetaxel—skin cancer	2.08e-05	0.000657	CcSEcCtD
Cabazitaxel—Fatigue—Docetaxel—skin cancer	2.08e-05	0.000656	CcSEcCtD
Cabazitaxel—Constipation—Docetaxel—skin cancer	2.06e-05	0.000651	CcSEcCtD
Cabazitaxel—Pain—Docetaxel—skin cancer	2.06e-05	0.000651	CcSEcCtD
Cabazitaxel—Feeling abnormal—Docetaxel—skin cancer	1.99e-05	0.000627	CcSEcCtD
Cabazitaxel—Nausea—Fluorouracil—skin cancer	1.99e-05	0.000626	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Docetaxel—skin cancer	1.97e-05	0.000622	CcSEcCtD
Cabazitaxel—Body temperature increased—Docetaxel—skin cancer	1.91e-05	0.000602	CcSEcCtD
Cabazitaxel—Abdominal pain—Docetaxel—skin cancer	1.91e-05	0.000602	CcSEcCtD
Cabazitaxel—Hypersensitivity—Docetaxel—skin cancer	1.78e-05	0.000561	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—skin cancer	1.75e-05	0.00179	CbGeAlD
Cabazitaxel—Asthenia—Docetaxel—skin cancer	1.73e-05	0.000546	CcSEcCtD
Cabazitaxel—Diarrhoea—Docetaxel—skin cancer	1.65e-05	0.000521	CcSEcCtD
Cabazitaxel—Dizziness—Docetaxel—skin cancer	1.6e-05	0.000503	CcSEcCtD
Cabazitaxel—Vomiting—Docetaxel—skin cancer	1.53e-05	0.000484	CcSEcCtD
Cabazitaxel—Headache—Docetaxel—skin cancer	1.51e-05	0.000477	CcSEcCtD
Cabazitaxel—Nausea—Docetaxel—skin cancer	1.43e-05	0.000452	CcSEcCtD
